Summary
The objectives of this study were to determine the optimal duration of acid suppression required for the initial treatment of gastric ulcer, and to compare the acid-suppressive effects of omeprazole with the H2-blocker cimetidine in patients with gastric ulcer as determined by 24-hour measurement of intragastric pH. Cimetidine was administered daily to 31 patients, while omeprazole was administered daily to 16 patients and every second day to an additional 16 patients. Ulcers healed within 2 months of treatment in 16 of the 31 patients administered cimetidine. The pH 4 holding time (the proportion of the total 24-hour period of measurement during which intragastric pH was 4 or higher) was 51.9 ± 4.6% of the 24-hour period of measurement for these 16 patients. Patients with unhealed ulcers had significantly shorter durations of ‘pH 4 holding time’ (15.8 ± 2.9% of the 24-hour period). There was no difference in the ‘pH 4 holding time’ of the 24-hour period between those receiving cimetidine who had a curable ulcer within 2 months and those administered omeprazole on alternate days (57.5 ± 7.9%). These findings suggest that obtaining the optimal duration of acid suppression is necessary for the treatment of gastric ulcers. Omeprazole administered as an alternate-day regimen is useful not only for the prevention of recurrence, but also for the initial treatment of gastric ulcer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fimmel CJ, Etienne A, Cilluffo T, et al. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology 1985; 88: 1842–51
Carlsson E, Larsson H, Mattsson H, et al. Pharmacology and toxicology of omeprazole — with special reference to the effects on the gastric mucosa. Scand J Gastroenterol 1986; 21 Suppl. 118: 31–8
Larrson H, Carlsson E, Mattsson H, et al. Plasma gastric and gastric enterochromaffin — like cell activation and proliferation. Gastroenterology 1986; 90: 391–9
Yamamoto Y, Yamada F, Sezai S, et al. Control of gastric pH with cimetidine — efficacy of twice daily drip infusion therapy [in Japanese]. Jpn Pharmacol Ther 1991; 19: 4251–4
Yamamoto Y, Sakurabayashi S, Sezai S, et al. Problems and significance of 24-hour continuous measurement of intragast-ric pH [in Japanese]. Gastroenterol Endosc 1993; 35: 2432–7
Fellenius E, Berglirdh T, Sachs G. Substituted benzimidazole inhibits gastric acid secretion by blocking (H-K) ATP-ase. Nature 1981; 290: 159–61
Cooperative study group: Double-blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Gut 1990; 31: 653–6
Savarino V, Mela GS, Zentilin P, et al. Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition?. Gastroenterology 1990; 99: 1858–60
Bürget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcer?. Gastroen-terology 1990; 99: 345–51
Samloff IM. Peptic ulcer: the many proteinases of aggression. Gastroenterology 1989; 96 Suppl.: 586–95
Nakada K. Prediction of gastric ulcer healing based on the mul-tivariate analysis of the endoscopic ultrasonographic findings [in Japanese]. Gastroenterol Endosc 1988; 30: 2527–36
Lauritsen K, Andersen BN, Laursen LS, et al. Omeprazole 20mg three days a week and 10mg daily in prevention of duodenal ulcer relapse. Gastroenterology 1991; 100: 663–9
Baak LC, Jansen JBMJ, Biemond I, et al. Weekend treatment with 20 and 40mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. Gut 1991; 32: 977–82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, Y., Sezai, S., Sakurabayashi, S. et al. Omeprazole Versus Cimetidine in the Treatment of Gastric Ulcers. Drug Invest 8, 377–382 (1994). https://doi.org/10.1007/BF03257453
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257453